Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome

• Main Authors: Subodh Verma (Author), Andrew Kosmopoulos (Author), Deepak L. Bhatt (Author), David Fitchett (Author), Anne Pernille Ofstad (Author), Christoph Wanner (Author), Michaela Mattheus (Author), Bernard Zinman (Author), Patrick R. Lawler (Author), Lawrence A. Leiter (Author)
• Format: Book
• Published: Elsevier, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives: REDUCE-IT showed that icosapent ethyl (IPE) improved cardiovascular (CV) outcomes in participants with established CV disease (CVD) or type 2 diabetes (T2D) and at least one additional risk factor plus mild-moderate hypertriglyceridemia and reasonably controlled low-density lipoprotein c...